Yang YY - Search Results

1

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.

Zhang Q, Yuan XF, Lu Y, Li ZZ, Bao SQ, Zhang XL, Yang YY, Fan DM, Zhang YZ, Wu CX, Guo HX, Zhang YJ, Ye Z, Xiong DS. Zhang Q, et al. Among authors: yang yy. Int J Cancer. 2017 Oct 1;141(7):1445-1457. doi: 10.1002/ijc.30846. Epub 2017 Jul 7. Int J Cancer. 2017. PMID: 28643325

2

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.

Zhang X, Yang Y, Zhang L, Lu Y, Zhang Q, Fan D, Zhang Y, Zhang Y, Ye Z, Xiong D. Zhang X, et al. J Hematol Oncol. 2017 Feb 23;10(1):56. doi: 10.1186/s13045-017-0397-z. J Hematol Oncol. 2017. PMID: 28228105 Free PMC article.

3

The development of bispecific antibodies and their applications in tumor immune escape.

Zhang X, Yang Y, Fan D, Xiong D. Zhang X, et al. Exp Hematol Oncol. 2017 May 2;6:12. doi: 10.1186/s40164-017-0072-7. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 28469973 Free PMC article. Review.

4

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells.

Yang Y, Zhang X, Lin F, Xiong M, Fan D, Yuan X, Lu Y, Song Y, Zhang Y, Hao M, Ye Z, Zhang Y, Wang J, Xiong D. Yang Y, et al. J Hematol Oncol. 2019 Apr 25;12(1):46. doi: 10.1186/s13045-019-0723-8. J Hematol Oncol. 2019. PMID: 31023384 Free PMC article.

5

An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma.

Fan D, Jiang L, Song Y, Bao S, Yang Y, Yuan X, Zhen Y, Yang M, Xiong D. Fan D, et al. Front Oncol. 2019 Sep 4;9:861. doi: 10.3389/fonc.2019.00861. eCollection 2019. Front Oncol. 2019. PMID: 31555598 Free PMC article.

6

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer.

Lin F, Xiong M, Hao W, Song Y, Liu R, Yang Y, Yuan X, Fan D, Zhang Y, Hao M, Ye Z, Lu Y, Zhang Y, Wang J, Xiong D. Lin F, et al. Front Oncol. 2021 Jan 5;10:615534. doi: 10.3389/fonc.2020.615534. eCollection 2020. Front Oncol. 2021. PMID: 33469516 Free PMC article.

7

A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma.

Xiong M, Liu R, Lei X, Fan D, Lin F, Hao W, Yuan X, Yang Y, Zhang X, Ye Z, Lu Y, Zhang Y, Wang J, Xiong D. Xiong M, et al. J Immunother. 2022 Feb-Mar 01;45(2):78-88. doi: 10.1097/CJI.0000000000000401. J Immunother. 2022. PMID: 34711791

8

Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma.

Yuan X, Lu Y, Yang Y, Tian W, Fan D, Liu R, Lei X, Xia Y, Yang L, Yan S, Xiong D. Yuan X, et al. Oncoimmunology. 2023 Jun 1;12(1):2219544. doi: 10.1080/2162402X.2023.2219544. eCollection 2023. Oncoimmunology. 2023. PMID: 37274296 Free PMC article.

9

Exploring the Molecular Mechanism of HongTeng Decoction against Inflammation based on Network Analysis and Experiments Validation.

Yang Y, Bi C, Li B, Li Y, Song Y, Zhang M, Peng L, Fan D, Duan R, Li Z. Yang Y, et al. Curr Comput Aided Drug Des. 2024;20(2):170-182. doi: 10.2174/1573409919666230612103201. Curr Comput Aided Drug Des. 2024. PMID: 37309760 Free PMC article.

10

Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Li Z, Liu L, Du C, Yu Z, Yang Y, Xu J, Wei X, Zhan F, Lai Y, Qiu L, Hao M. Li Z, et al. Cancer Gene Ther. 2020 Dec;27(12):869-877. doi: 10.1038/s41417-020-0161-3. Epub 2020 Jan 28. Cancer Gene Ther. 2020. PMID: 31988477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,494 results

Search Page

Filters